A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...

Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of Science and Technology, announced a targeted ...

This groundbreaking perspective transforms our understanding of how Parkinson’s disease develops and progresses, opening new possibilities for prevention and treatment. In the past, Parkinson ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

Over time, the disease can also affect memory and lead to dementia. A similar condition called Lewy Body Dementia (LBD), ...

These include, to name a few, a transformed understanding of Parkinson’s genetics, a crucial Parkinson’s biomarker discovered in 2023 and standing armies of clinical trial participants.

Researchers have developed a targeted nano formulation that can help sustained release of a hormone called 17β-Estradiol which is crucial for managing Parkinson’s Disease (PD).Many neurodegenerative a ...

Yulan Xiong and her team have discovered a much-searched-for regulator that plays a key role in genetic causes of Parkinson's ...

There may be a link between hearing impairment and an increased risk of developing Parkinson’s according to research led by Lancaster University. This is one of the first studies to examine whether ...

Gain a comprehensive understanding of the Parkinson’s disease clinical trial landscape and access actionable insights to support your development goals. Download the full report to inform your ...